Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

Navigating Key Endpoints in Oncology Clinical Trials Here's a guide to understanding endpoints you will likely encounter in cancer clinical trials. Medscape Medical News, October 18, 2023 ESMO 2023 ...

Please provide your email address to receive an email when new articles are posted on . Among a group of patients with differentiated thyroid cancer, 10-year disease-specific survival was 97.2%.

CHAPEL HILL, N.C. (WTVD) -- UNC Lineberger is leading a new trial into a possible treatment option for anaplastic thyroid cancer. "This is the one cancer diagnosis that I personally dread having to ...

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

After undergoing surgery to remove an overactive thyroid in 2014, games designer and publisher Xeo Lye had jokingly asked his doctor how long he could survive without thyroid hormone replacement pills ...